We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+30.71%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$262M
AUM Growth
+$42.4M
Cap. Flow
-$3.78M
Cap. Flow %
-1.44%
Top 10 Hldgs %
75.81%
Holding
46
New
12
Increased
5
Reduced
5
Closed
13

Top Buys

1
ARDX icon
Ardelyx
ARDX
+$13.7M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$13.7M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$8.71M
4
DERM
Dermira, Inc.
DERM
+$8.05M
5
KA
Kineta, Inc. Common Stock
KA
+$8M

Top Sells

1
TVTX icon
Travere Therapeutics
TVTX
+$21.8M
2
CYTK icon
Cytokinetics
CYTK
+$13.5M
3
XLRN
Acceleron Pharma
XLRN
+$12.6M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.51M
5
EPZM
Epizyme, Inc
EPZM
+$7.73M

Sector Composition

1 Healthcare 85.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$663M
$44.6M 17.06%
3,355,516
+453,558
+16% +$5.3M
LKFT
2
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$32.4M 12.37%
500,576
+61,191
+14% +$3.45M
ASMB icon
3
Assembly Biosciences
ASMB
$528M
$21.2M 8.11%
245,264
– –
DERM
4
DELISTED
Dermira, Inc.
DERM
$17.7M 6.75%
522,000
+250,000
+92% +$8.05M
ARDX icon
5
Ardelyx
ARDX
$1.28B
$17M 6.48%
+1,310,023
New +$13.7M
KURA icon
6
Kura Oncology
KURA
$1B
$16.3M 6.24%
2,611,906
+146,620
+6% +$743K
FPRX
7
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$15M 5.75%
+286,612
New +$13.7M
KYNB
8
Kyntra Bio
KYNB
$30M
$14.2M 5.43%
27,447
-4,103
-13% -$1.93M
AGIO icon
9
Agios Pharmaceuticals
AGIO
$2.36B
$10.6M 4.04%
+200,000
New +$8.71M
KA
10
DELISTED
Kineta, Inc. Common Stock
KA
$9.39M 3.59%
+4,302
New +$8M
AKAO
11
DELISTED
Achaogen Inc
AKAO
$8.05M 3.08%
1,679,707
+107,999
+7% +$431K
CYTK icon
12
Cytokinetics
CYTK
$11.2B
$7.77M 2.97%
846,654
-1,293,043
-60% -$13.5M
KIN
13
DELISTED
Kindred Biosciences, Inc.
KIN
$7.15M 2.73%
1,432,765
– –
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$2.11B
$5.42M 2.07%
357,365
– –
ONC
15
BeOne Medicines Ltd
ONC
$32.5B
$5.04M 1.93%
163,470
-11,910
-7% -$346K
ASND icon
16
Ascendis Pharma A/S
ASND
$17.4B
$4.41M 1.68%
+219,200
New +$3.62M
ONCE
17
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.12M 1.57%
+68,600
New +$3.95M
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
$3.89M 1.49%
+94,626
New +$3.59M
NBRV
19
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$3.87M 1.48%
2,196
-55
-2% -$106K
NTLA icon
20
Intellia Therapeutics
NTLA
$1.84B
$3.42M 1.31%
200,858
-109,837
-35% -$2.13M
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
$3.31M 1.27%
+598,062
New +$2.74M
OMED
22
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$3.04M 1.16%
+265,784
New +$3.09M
FATE icon
23
Fate Therapeutics
FATE
$346M
$1.84M 0.7%
+590,527
New +$1.43M
SYRS
24
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$882K 0.34%
+6,360
New +$807K
AKTX
25
Akari Therapeutics
AKTX
$22M
– –
-79
Closed -$856K
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return